期刊文献+

不同频率血液灌流治疗对甲状旁腺激素和血清钙磷清除的研究 被引量:20

Clinical investigation of various hemoperfusion frequencies on cleaning parathyroid hormone, calcium and phosphorus in maintenance hemodialysis patients
下载PDF
导出
摘要 目的探讨不同频率血液灌流治疗对维持性血液透析患者甲状旁腺激素和血清钙、磷清除的效果。方法选择长期维持性血液透析患者78例,随机分为4组,A组18例为对照组,常规血液透析。其余3组在常规血液透析基础上联合血液灌流,B组22例血液灌流每周1次,C组20例血液灌流每周2次,D组18例血液灌流每2周1次。4组患者均观察12周,测量治疗前及治疗后2周、4周、6周、8周、10周、12周7个时间点血清中的钙、磷和甲状旁腺激素的浓度并进行比较分析。结果①各实验组患者的血清PTH浓度随着治疗时间的延续呈下降趋势(P<0.05),常规血液透析联合血液灌流降低PTH的疗效优于常规血透(P<0.05);②每周1次、每周2次血液灌流疗效优于每2周1次(P<0.05);治疗后4周、6周时,每周2次疗效好于每周1次(P<0.05),其余时点每周1次、每周2次的疗效相当。③随着治疗时间的延续各组患者的钙磷乘积总体呈下降趋势,但各组患者的钙磷乘积下降程度无明显差异(P>0.05)。结论①采用每周1次血液灌流频率,对PTH的清除既能达到临床疗效,又能明显减少费用。②血液灌流频率越高,PTH浓度在初期下降越快。③血液灌流串联血液透析能降低钙磷乘积,但与血液灌流频率是否相关尚待证实。 Objective To investigate the best frequency of hemoperfusion (HP) on cleaning parathyroid hormone (PTH),calcium (Ca2+) and phosphorus (P3+) in maintenance hemodialysis (MHD) patients.Methods A total of 78 MHD patients were recruited.They were randomly assigned into 4 groups:patients in group A were treated with hemodialysis only as the control group (n=l 8); patients in group B,C and D were treated with the combination of hemoperfusion and hemodialysis (HP+HD),in which HP was performed once a week in group B (n=22),HP twice a week in group C (n=20),and HP once every two weeks in group D (n=18).The treatments were lasted for 12 weeks.Serum Ca2+,P3+,and PTH were measured at the time points of before treatment,2nd,4th,6th,8th,10th,and 12th weeks after the treatments.Results Serum PTH decreased after the treatments in all of the 4 groups (P<0.05).Serum PTH decreased more in groups B,C and D (HP+ HD groups) than in group A (P<0.05),and more in groups B and C than in group D (P<0.05).The therapeutic effect was better in group C than in group B at the 4th and 6th weeks after treatment (P<0.05),but was similar between groups B and C at the 2nd,8th,10th,and 12th weeks after the treatment.Calcium-phosphorus product decreased gradually in the 4 groups after the treatment,but without significant differences at different time points (P>0.05).Conclusion HP once a week can achieve the cleaning of PTH with relatively lower cost.The higher the HP frequency,the faster the PTH concentration falls at the early stage.The combination of HP+HD can reduce the calcium-phosphorus product,but whether this therapeutic effect is related to HP frequency is uncertain.
出处 《中国血液净化》 2014年第5期380-383,共4页 Chinese Journal of Blood Purification
关键词 血液透析 血液灌流 不同频率 甲状旁腺激素 Hemodialysis Hemoperfusion Treatment frequency Parathyroid hormone
  • 相关文献

参考文献6

二级参考文献38

  • 1王俊霞.血液灌流联合血液透析治疗尿毒症性心包炎临床观察[J].临床肾脏病杂志,2005,5(6):274-274. 被引量:5
  • 2章俊,李幼姬,叶任高.血液透析患者甲状旁腺素和血小板胞内游离钙变化及相互关系[J].中华肾脏病杂志,1996,12(5):269-272. 被引量:3
  • 3王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:8262.
  • 4Yasunaga C, Matsuo K, Yanagida T, et al. Early effects of parathyroidectomy on erythropoietin production in secondary hyperpar athyroidism [ J ]. American Journal of Surgery, 2002,183 (2) : 199-204.
  • 5Longdon GM, Marry C, Marchais S J, et al. Arterial calcifications and bone histomorpiometry in end-stage renal disease [ J ]. Journal of the American Society of Nephrology, 2004, 15 : 1943-1951.
  • 6Brancaccio D, Cozzolino M, Callieni M. Hyperparathyroidism and anemia in uremic subjects: a combined therapentic approach [ J ]. Journal of the American Society of Nephrology, 2004,15 ( suppll ) :212-214.
  • 7Block GA, Klassen PS, Lazarus JM, et al. Mineralmetabolism, mortality, and morbidity in maintenance hemodialysis [J]. J Am Soc Nephrol,2004,15 (8):2208- 2218.
  • 8Kestenbaum B, Sampson JN, Rudser KD, et al. Serum phosphate levels and mortality risk among people with chronic kidney disease[J]. J Am Soc Nephrol,2005,16(2): 520-528.
  • 9Meeus F, Kourilsky O, Guerin AP, et al. Pathophysiology of cardiovascular disease in hemodialysis patients[J]. Kid- ney Int Suppl,2000,76:S140-S147.
  • 10Attman PO, Samuelsson OG, Moberly J, et al Apolipoprotein B-containing lipoproteins in renal failure the relation to mode of dialysis[J]. Kidney Int,1999,55(4) 1536-1542.

共引文献47

同被引文献164

  • 1李秀丽.血液灌流串联血液透析治疗尿毒症皮肤瘙痒16例[J].解放军医药杂志,2010,22(S1):17-18. 被引量:5
  • 2Coussa RG,Shah S,Jain P,et al.Microencapsulated Saccharomyces cerevisiae column bioreactor for potential use in renal failure uremia[J].Artif Cells Blood Substit Immobil Biotechnol,2012,40(2):103-112.
  • 3Salehi M,Sohrabi Z,Ekramzadeh M,et al.Selenium supplementation improves the nutritional status of hemodialysis patients:a randomized,double-blind,placebo-controlled trial[J].Nephrol Dial Transplant,2013,28(3):716-723.
  • 4Delporte C,Franck T,Noyon C,et al.Simultaneous measurement of protein-bound 3-chlorotyrosine and homocitrulline by LC-MS/MS after hydrolysis assisted by microwave:application to the study of myeloperoxidase activity during hemodialysis[J].Talanta,2012,15,99:603-609.
  • 5Rashid-Farokhi F,Pourdowlat G,Nikoonia MR,et al.Uremic pleuritis in chronic hemodialysis patients[J].Hemodial Int,2013,17(1):94-100.
  • 6Shimoyama Y,Tsuruta Y,Niwa T.Coronary artery calcification score is associated with mortality in Japanese hemodialysis patients[J].J Ren Nutr,2012,22(1):139-142.
  • 7李军.血液灌流联合血液透析治疗尿毒症并发症36例临床体会[J].中国保健营养(上旬刊),2014,24(2):708-709.
  • 8Palmer SC,Hayen A,Macaskill P,et al.Serum levels of phosphorus,parathyroid hormone,and calcium ang risks of death and cardiovascular disease in individuals with chronic kidney disease:a systematic review and meta-analysis.JAMA,2011,305(11):1119-1127.
  • 9Martin K J, Gonzalez E A. Prevention and control of phosphate retention hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat[J].Clin J Am Soc Nephrol,2011,6(2):440-446.
  • 10Gorriz J L, Molina P, Bover J ,et al. Characteristics of bone mineral metabolism in patients with stage 3-5 chronic kidney disease not on dialysis: result of the OSERCE study[J]. Nerologia,2013,33(1):46-60.

引证文献20

二级引证文献258

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部